70 related articles for article (PubMed ID: 16467016)
1. Intermittent dosing of biologics for psoriasis.
Feldman SR
J Dermatolog Treat; 2006; 17(1):5. PubMed ID: 16467016
[No Abstract] [Full Text] [Related]
2. Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series.
Conley J; Nanton J; Dhawan S; Pearce DJ; Feldman SR
J Dermatolog Treat; 2006; 17(2):86-9. PubMed ID: 16766332
[TBL] [Abstract][Full Text] [Related]
3. Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.
Gordon KB; Gottlieb AB; Leonardi CL; Elewski BE; Wang A; Jahreis A; Zitnik R
J Dermatolog Treat; 2006; 17(1):9-17. PubMed ID: 16467018
[TBL] [Abstract][Full Text] [Related]
4. Side effects of the biologics.
Heymann WR
J Am Acad Dermatol; 2005 Oct; 53(4):692-3. PubMed ID: 16198794
[No Abstract] [Full Text] [Related]
5. Switching between antitumour necrosis factor alpha biologic agents--is patient weight an important consideration?
Downs AM
Br J Dermatol; 2009 May; 160(5):1123-4. PubMed ID: 19292716
[No Abstract] [Full Text] [Related]
6. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
Safa G; Loppin M; Bousser AM; Barbarot S
J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
[No Abstract] [Full Text] [Related]
7. Angiokeratoma induced by injection of etanercept for psoriasis.
Bathelier E; Gunera-Saad N; Bérard F; Nicolas JF
J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S124-5. PubMed ID: 19119125
[No Abstract] [Full Text] [Related]
8. Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes.
Kircik L; Bagel J; Korman N; Menter A; Elmets CA; Koo J; Yang YC; Chiou CF; Dann F; Stevens SR;
J Drugs Dermatol; 2008 Mar; 7(3):245-53. PubMed ID: 18380206
[TBL] [Abstract][Full Text] [Related]
9. Etanercept and recalcitrant acrodermatitis continua of Hallopeau.
Nikkels AF; Piérard GE
J Drugs Dermatol; 2006 Sep; 5(8):705-6. PubMed ID: 16991229
[No Abstract] [Full Text] [Related]
10. Rapid response of nail psoriasis to etanercept.
Rallis E; Stavropoulou E; Rigopoulos D; Verros C
J Rheumatol; 2008 Mar; 35(3):544-5. PubMed ID: 18322982
[No Abstract] [Full Text] [Related]
11. The role of the QuantiFERON-TB Gold test as screening prior to administration of tumor necrosis factor inhibitors.
Martinez LC; Harrison-Balestra C; Caeiro JP; Nousari CH
Arch Dermatol; 2007 Jun; 143(6):809-10. PubMed ID: 17576961
[No Abstract] [Full Text] [Related]
12. Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept.
Fabrizi G; Guerriero C; Pagliarello C
Eur J Dermatol; 2007; 17(3):245. PubMed ID: 17478389
[No Abstract] [Full Text] [Related]
13. Consecutive use of different biological therapies in the treatment of psoriasis.
Costanzo A; Papoutsaki M; Mazzotta A; Chimenti S
Br J Dermatol; 2007 Aug; 157(2):394. PubMed ID: 17553044
[No Abstract] [Full Text] [Related]
14. Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection.
Cassano N; Vena GA
Int J Dermatol; 2008 Sep; 47(9):980-1. PubMed ID: 18937672
[No Abstract] [Full Text] [Related]
15. Severe psoriasis pustulosa palmaris et plantaris (Barber-Königsbeck) treated successfully with soluble tumour necrosis factor receptor fusion protein (etanercept).
Kasche A; Pfab F; Hein R; Athanasiadis GI; Ollert M; Ring J; Eberlein-König B
J Eur Acad Dermatol Venereol; 2007 Feb; 21(2):255-7. PubMed ID: 17243968
[No Abstract] [Full Text] [Related]
16. Experience with biologics for psoriasis in daily practice: rotational therapy is required.
Saccomani C; Penz S; Guerre-Schmidt R; Pelletier F; Puzenat E; Riou-Gotta MO; Humbert P; Aubin F
J Dermatolog Treat; 2011 Jun; 22(3):151-2. PubMed ID: 20524880
[No Abstract] [Full Text] [Related]
17. Generalized pustular psoriasis and cryptogenic organizing pneumonia.
Webber NK; Elston CM; O'Toole EA
Br J Dermatol; 2008 Apr; 158(4):853-4. PubMed ID: 18241268
[No Abstract] [Full Text] [Related]
18. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
19. Development of autoimmune hepatitis in a child with systemic-onset juvenile idiopathic arthritis during therapy with etanercept.
Fathalla BM; Goldsmith DP; Pascasio JM; Baldridge A
J Clin Rheumatol; 2008 Oct; 14(5):297-8. PubMed ID: 18824922
[No Abstract] [Full Text] [Related]
20. Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis.
Abbasi NR; Orlow SJ
Pediatr Dermatol; 2009; 26(1):118. PubMed ID: 19250435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
